Sort
23,748 grants matching “melanoma”
Melanoma vaccines using MHC-associated peptides
$339,040Craig Lee Slingluff · University Of Virginia · R01 · FY2010 · CA
Melanoma vaccines using MHC-associated peptides
$339,040Craig Lee Slingluff · University Of Virginia · R01 · FY2009 · CA
Melanoma vaccines using MHC-associated peptides
$339,040Craig Lee Slingluff · University Of Virginia · R01 · FY2008 · CA
Context-specific Functions of CDK8
$338,960Jun-Yuan Ji · Tulane University Of Louisiana · R01 · FY2022 · GM
Context-specific Functions of CDK8
$338,960Jun-Yuan Ji · Tulane University Of Louisiana · R01 · FY2023 · GM
Design of de novo interleukin mimics for targeted immunotherapy
$338,955David Baker · University Of Washington · R01 · FY2022 · CA
Design of de novo interleukin mimics for targeted immunotherapy
$338,953David Baker · University Of Washington · R01 · FY2023 · CA
Role for TbetaRIII Shedding in the Tumor Microenvironment
$338,901Gerard C Blobe · Duke University · R01 · FY2021 · CA
Lymphatic Imaging
$338,901Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Role for TbetaRIII Shedding in the Tumor Microenvironment
$338,901Gerard C Blobe · Duke University · R01 · FY2020 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$338,882Anna E Vilgelm · Ohio State University · R37 · FY2025 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$338,864Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$338,826Benjamin Izar · Columbia University Health Sciences · R37 · FY2025 · CA
HSV VECTORS FOR THE DESTRUCTION OF BRAIN TUMORS
$338,794University Of Pennsylvania · R01 · FY2003 · NS
HSV VECTORS FOR THE DESTRUCTION OF BRAIN TUMORS
$338,794University Of Pennsylvania · R01 · FY2002 · NS
Adoptive CD4 T Cell Therapy of Melanoma
$338,772Fred Hutchinson Cancer Research Center · R21 · FY2002 · CA
Biospecimen and Pathology Core
$338,762Xiaowei Xu · Wistar Institute · P50 · FY2017 · CA
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
$338,743Georg T Wondrak · University Of Arizona · R01 · FY2020 · CA
Regulation of ROR-gt in colonic inflammation
$338,643Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2019 · DK
Defining the contribution of ATR to MC1R-enhanced DNA repair in melanocytes
$338,625John A Dorazio · University Of Kentucky · R01 · FY2018 · CA
Defining the contribution of ATR to MC1R-enhanced DNA repair in melanocytes
$338,625John A Dorazio · University Of Kentucky · R01 · FY2020 · CA
Defining the contribution of ATR to MC1R-enhanced DNA repair in melanocytes
$338,625John A Dorazio · University Of Kentucky · R01 · FY2016 · CA
Defining the contribution of ATR to MC1R-enhanced DNA repair in melanocytes
$338,625John A Dorazio · University Of Kentucky · R01 · FY2017 · CA
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$338,537Arlene H Sharpe · Harvard Medical School · U54 · FY2020 · CA
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
$338,521Li Lily Wang · Medical College Of Wisconsin · R01 · FY2015 · CA